Loading data for DMIIU — first visit, this takes a few seconds.
Drugs Made In America Acquisition II Cor... (DMIIU)
NasdaqGM: DMIIU
· 即時價格 · USD
10.20
+0.00 (0.00%)
收盤價： Aug 17, 2026, 8:00 PM
股價、關鍵數字和最新消息，都在這一頁。
Drugs Made In America Acquisition II Corp.（DMIIU）股價、分析與資料
無可用資料
| 買價 | 9.96 |
| 市值 | n/a |
| 營收 (ttm) | n/a |
| 淨利（ttm） | 13M |
| 0.00 | |
| n/a | |
| n/a | |
| n/a | |
| P/B (ttm) | -36.30 |
| P/S (ttm) | 0.00 |
| 財報日期 | n/a |
| 賣價 | 10.12 |
| 成交量 | 25 |
| 20 日平均成交量 | 477 |
| 開盤價 | 10.19 |
| 前收盤價 | 10.20 |
| 當日區間 | 10.20 - 10.20 |
| 52 週範圍 | 9.94 - 10.80 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 DMIIU
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York...
完整的公司簡介財務表現
Drugs Made In America Acquisition II 在 2025 年的營收為 0，較前一年的 n/a 增加 undefined%。 淨利為 4.19M，較前期增加 undefined%。
財務報表財報驚奇
Drugs Made In America Acquisition II 已於 Invalid Date 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 低於預期 , 年增 NaN% 成長.
